Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Antengene to Present Four Preclinical Abstracts at AACR 2024, Highlighting Focus on Cancer Immunology, Targeted Agents and Novel Technology Platforms 2024-03-06 08:30
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024 2024-03-06 05:30
Life Fitness Delivers on the Future of Fitness, Debuting State-of-the-Art Cardio Line with Next-Gen Biomechanics, Symbio™, at IHRSA 2024 2024-03-06 00:00
Datasea Expects Approximately 1,128% Revenue Growth in 2024 2024-03-05 23:45
DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador 2024-03-05 22:00
Laifen Launches the Laifen Wave Electric Toothbrush, a Revolutionary New Oral Health and Wellness Experience 2024-03-05 22:00
Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production 2024-03-05 22:00
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment 2024-03-05 21:00
Angel Yeast Hosts Webinar with PPTI to Promote Sustainable Development of Proteins 2024-03-05 21:00
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries 2024-03-05 21:00
IRBM Expands Global Reach in Drug Discovery with New Boston Office 2024-03-05 20:24
One Million Global Healthcare Seekers Embrace MedicalTourism.com: Medical Tourism Magazine Leads the Way 2024-03-05 16:00
Cetaphil® Strengthens Ties with the Malaysian Community through Collaborative Partnership with Mira Filzah as the New Face of the Brand in 2024 2024-03-05 14:58
Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer 2024-03-05 13:35
First Patient Treated in Phase 2 GvHD Trial 2024-03-05 10:08
Telix to Acquire ARTMS, Inc. and its Advanced Isotope Production Platform 2024-03-05 07:01
Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery 2024-03-05 06:55
Cyient Partners with MassMedic to Accelerate MedTech Innovation 2024-03-04 22:00
Optimum Nutrition Launches New Global Marketing Campaign "Unlock More You" 2024-03-04 22:00
ACROBiosystems Launches New Initiative to Support Cell and Gene Manufacturers 2024-03-04 22:00
1 31 32 33 34 35 1531